Efficacy of telbivudine with conditional tenofovir intensification in patients with chronic hepatitis B: results from the 2-year roadmap strategy

Efficacy of telbivudine with conditional tenofovir intensification in patients with chronic hepatitis B: results from the 2-year roadmap strategy

Background: A 2-year roadmap study was conducted to evaluate the efficacy and safety of tenofovir intensification at Week 24 in patients with chronic hepatitis B (CHB) receiving telbivudine. Scope: A prospective multicenter study was conducted in treatment-naive patients with hepatitis B e antige...

Full description

Bibliographic Details
Main Authors: Teerha Piratvisuth, Piyawat Komolmit, Henry LY Chan, Tawesak Tanwandee, Wattana Sukeepaisarnjaroen, Mário G Pessoa, Eduardo Fassio, Suzane K Ono, Fernando Bessone, Jorge Daruich, Stefan Zeuzem, Michael Manns, Alkaz Uddin, Yuhong Dong, Aldo Trylesinski
Format: Article
Language:English
Published: BioExcel Publishing Ltd 2016-04-01
Series:Drugs in Context
Subjects:
chronic hepatitis B
glomerular filtration rate
hepatitis B e antigen
intensification
roadmap
telbivudine
tenofovir
virologic breakthrough
Online Access:http://www.drugsincontext.com/efficacy-of-telbivudine-with-conditional-tenofovir-intensification-in-patients-with-chronic-hepatitis-b-results-from-the-2-year-roadmap-strategy/

Internet

http://www.drugsincontext.com/efficacy-of-telbivudine-with-conditional-tenofovir-intensification-in-patients-with-chronic-hepatitis-b-results-from-the-2-year-roadmap-strategy/

Similar Items